Stocktoria

U S PHYSICAL THERAPY INC /NV USPH

NYSE · stock · Services-Health Services · website · IPO 1992-05-29

U S PHYSICAL THERAPY INC /NV statistics & valuation

P / E25.5×
P / S1.3×
P / B2.1×
Net margin5.1%
Net debt$117.0M
Net debt / EBITDA1.1×
Enterprise value USD$1.1B
EV / EBITDA10.3×
Earnings yield EBIT/EV7.7%
Return on capital8.1%
Graham number -61.3%$31.69

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($31.69); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
5.80% 5.40% 7.70% 8.30% 8.30% 8.20% 5.80% 4.70% 4.70% 5.10% 2016201720182019202020212022202320242025
Gross margin (%)
23.00% 21.90% 22.40% 23.30% 22.30% 23.70% 20.30% 20.10% 18.50% 19.20% 2016201720182019202020212022202320242025
Operating margin (%)
13.90% 13.20% 13.30% 14.00% 12.40% 14.30% 10.30% 8.40% 9.40% 11.10% 2016201720182019202020212022202320242025
Return on equity (%)
10.90% 10.80% 16.10% 16.60% 12.70% 13.70% 10.10% 5.90% 6.40% 8.30% 2016201720182019202020212022202320242025
Shares outstanding
12.5M 12.6M 12.7M 12.8M 12.8M 12.9M 13.0M 14.2M 15.1M 15.2M 2016201720182019202020212022202320242025
Net debt ($)
$31.8M $38.8M $16.5M $27.5M -$11.4M $89.8M $144.2M -$13.8M $101.2M $117.0M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
5.90% 5.30% 7.90% 6.40% 5.90% 5.40% 3.70% 2.80% 2.70% 3.30% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
0.27× 0.29× 0.18× 0.21× 0.08× 0.40× 0.55× 0.29× 0.29× 0.32× 2016201720182019202020212022202320242025
EPS ($)
$2.45 $2.48 $2.41 $2.25 $1.28 $1.84 $1.42 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

U S PHYSICAL THERAPY INC /NV trades at about 57.7× earnings — above its 10-year norm (10-year range 23.9×–72.1×, median 47.8×).

23.9× 72.1×

Shaded band = 10-year range (23.9×–72.1×); dot = today's 57.7×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin19.2%18.5%20.1%20.3%23.7%22.3%23.3%22.4%21.9%23.0%
Operating margin11.1%9.4%8.4%10.3%14.3%12.4%14.0%13.3%13.2%13.9%
Net margin5.1%4.7%4.7%5.8%8.2%8.3%8.3%7.7%5.4%5.8%
Return on assets3.3%2.7%2.8%3.7%5.4%5.9%6.4%7.9%5.3%5.9%
Return on equity8.3%6.4%5.9%10.1%13.7%12.7%16.6%16.1%10.8%10.9%
Debt / equity0.32×0.29×0.29×0.55×0.40×0.08×0.21×0.18×0.29×0.27×
Current ratio1.011.182.281.301.140.941.411.891.952.68

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.